Option Care Health price target raised to $33 from $32 at Barrington

Barrington raised the firm’s price target on Option Care Health (OPCH) to $33 from $32 and keeps an Outperform rating on the shares. The company provided a preliminary look at its Q4 and gave a better than expected outlook for fiscal 2025, the analyst tells investors in a research note. The firm suspects Option Cares financial guidance will bolster investor confidence. While it continues to have concerns regarding the biosimilar competition issue, Barrington is “breathing a sigh of relief that the company will be able to absorb the Stelara-related hit” and still likely show adjusted EBITDA growth in fiscal 2025.